Smoking as a risk factor for renal injury in essential hypertension

Nephron - Clinical Practice

Volumn 103, Issue 4, 2006, Pages

  Tylicki, Leszek ^a   Puttinger, Heidemarie ^b   Rutkowski, Przemyslaw ^a   Rutkowski, Boleslaw ^a   Hörl, Walter H ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Essential hypertension; Hypertensive nephropathy; Nephrosclerosis

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE; ISOPROSTANE DERIVATIVE; N ACETYL BETA GLUCOSAMINIDASE; TRANSFORMING GROWTH FACTOR BETA1; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; ENDOTHELIUM INJURY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; KIDNEY FIBROSIS; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RISK FACTOR; SMOKING; SMOKING HABIT; TUBULAR DYSFUNCTION; URINARY EXCRETION;

ALBUMINURIA; BODY MASS INDEX; CASE-CONTROL STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION, RENAL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION; VON WILLEBRAND FACTOR;

EID: 33746325452     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092908     Document Type: Article

References (35)

1. Tylicki L, Rutkowski B: Hypertensive nephropathy: pathogenesis, diagnosis and treatment. Pol Merkuriusz Lek 2003;14:168-173.
2. Rutkowski B, Tylicki L, Manitius J, Lysiak-Szydlowska W: Hypertensive nephropathy: an increasing clinical problem. Miner Electrolyte Metab 1999;25:65-68.
3. Toto RD, Mitchell HC, Smith RD, Lee HC, Mclntire D, Pettinger WA: 'Strict' blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int 1995;48:851-859.
4. Rostand SG, Brown G, Kirk KA, Rutsky EA, Dustan HP: Renal insufficiency in treated essential hypertension. N Engl J Med 1989;320:684-688.
5. Weisstuch JM, Dworkin LD: Does essential hypertension cause end-stage renal disease? Kidney Int Suppl 1992;36:S33-37.
6. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 1995;92:2735-2739.
7. Fisher ER, Pirog J: Renal arteriolar obstruction without hypertension. Nephron 1976;16:433-438.
8. Moritz A, Oldt M: Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 1937;13:679-728.
9. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J: Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-18.
10. Tylicki L, Rutkowski B, Horl W: Multifactorial determination of hypertensive nephroangiosclerosis. Kid Blood Press Res 2002;25:241-353.
11. Orth SR, Ritz E: The renal risk of smoking: an update. Curr Opin Nephrol Hypertens 2002;11:483-488.
12. Orth SR: Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function. J Am Soc Nephrol 2004;15(suppl 1):S58-63.
13. Muhlhauser I: Cigarette smoking and diabetes: an update. Diabet Med 1994;11:336-343.
14. Orth SR, Stockmann A, Conradt C, Ritz E, Ferro M, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schafer K, Sieberth HG, Wanner C, Watschinger B, Zucchelli P: Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998;54:926-931.
15. Stengel B, Couchoud C, Cenee S, Hemon D: Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int 2000;57:2519-2526.
16. Gambaro G, Verlato F, Budakovic A, Casara D, Saladini G, Del Prete D, Bertaglia G, Masiero M, Checchetto S, Baggio B: Renal impairment in chronic cigarette smokers. J Am Soc Nephrol 1998;9:562-567.
17. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG: Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int 2000;57:2072-2079.
18. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, de Jong PE: Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000;133:585-591.
19. Regalado M, Yang S, Wesson DE: Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 2000;35:687-694.
20. Mimran A, Ribstein J, DuCailar G, Halimi JM: Albuminuria in normals and essential hypertension. J Diab Compl 1994;8:150-156.
21. Horner D, Fliser D, Klimm HP, Ritz E: Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. J Hypertens 1996;14:655-660.
22. Dundar M, Kocak I, Culhaci N: Effects of long-term passive smoking on the diameter of glomeruli in rats: histopathological evaluation. Nephrology (Carlton) 2004;9:53-57.
23. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE: Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996;334:150-154.
24. Benowitz NL, Kuyt F, Jacob P 3rd: Influence of nicotine on cardiovascular and hormonal effects of cigarette smoking. Clin Pharmacol Ther 1984;36:74-81.
25. Kilaru S, Frangos SG, Chen AH, Gortler D, Dhadwal AK, Araim O, Sumpio BE: Nicotine: A review of its role in atherosclerosis. J Am Coll Surg 2001;193:538-546.
26. Tracy RE, Strong JP, Newman WP 3rd, Malcom GT, Oalmann MC, Guzman MA: Renovasculopathies of nephrosclerosis in relation to atherosclerosis at ages 25 to 54 years. Kidney Int 1996;49:564-570.
27. Bleyer AJ, Chen R, D'Agostino RB Jr, Appel RG: Clinical correlates of hypertensive end-stage renal disease. Am J Kidney Dis 1998;31:28-34.
28. Kasiske BL: Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 1987;31:1153-1159.
29. Cluette-Brown J, Mulligan J, Doyle K, Hagan S, Osmolski T, Hojnacki J: Oral nicotine induces an atherogenic lipoprotein profile. Proc Soc Exp Biol Med 1986;182:409-413.
30. Bylock A, Bondjers G, Jansson I, Hansson HA: Surface ultrastructure of human arteries with special reference to the effects of smoking. Acta Pathol Microbiol Scand [A] 1979;87A:201-209.
31. Thyberg J: Effects of nicotine on phenotypic modulation and initiation of DNA synthesis in cultured arterial smooth muscle cells. Vir chows Arch [B] 1986;52:25-32.
32. Kannel WB, D'Agostino RB, Belanger AJ: Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham Study. Am Heart J 1987;113:1006-1010.
33. Heitzer T, Just H, Munzel T: Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996;94:6-9.
34. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ 2nd: Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198-1203.
35. Tylicki L, Rutkowski B, Horl WH: Antioxidants: a possible role in kidney protection. Kid Blood Press Res 2003;26:303-314.